• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Differential consequences of two distinct AhR ligands on innate and adaptive immune responses to influenza A virus

tetano

Editor, Senior Moderator
Toxicol Sci. 2013 Nov 5. [Epub ahead of print]
Differential consequences of two distinct AhR ligands on innate and adaptive immune responses to influenza A virus.
Wheeler JL, Martin KC, Resseguie E, Lawrence BP.
Source

Department of Environmental Medicine and Toxicology Graduate Program University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Abstract

Immune modulation by the aryl hydrocarbon receptor (AhR) has been primarily studied using 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD). Recent reports suggest another AhR ligand, 6-formylindolo[3,2-b]carbazole (FICZ), exhibits distinct immunomodulatory properties, but side-by-side comparisions of these two structurally distinct, high affinity ligands are limited. In this study, the effects of in vivo AhR activation with TCDD and FICZ were directly compared in a mouse model of influenza virus infection using three key measures of the host response to infection: pulmonary neutrophilia, inducible nitric oxide synthase (iNOS) levels, and the virus-specific CD8+ T cell response. By this approach, the consequences of AhR activation on innate and adaptive immune responses to the same antigenic challenge were compared. A single dose of TCDD elicited AhR activation that is sustained for the duration of the host's response to infection, and modulated all three responses to infection. In contrast, a single dose of FICZ induced transient AhR activation, and had no effect on the immune response to infection. Micro-osmotic pumps and Cyp1a1-deficient mice were utilized to augment FICZ-mediated AhR activation in vivo, in order to assess the effect of transient versus prolonged AhR activation. Prolonged AhR activation with FICZ did not affect neutrophil recruitment or pulmonary iNOS levels. However, FICZ-mediated AhR activation diminished the CD8+ T cell response in Cyp1a1-deficient mice in a similar manner to TCDD. These results demonstrate that immunomodulatory differences in the action of these two ligands are likely due to not only the duration of AhR activation, but also the cell types in which the receptor is activated.
KEYWORDS:

AhR, FICZ, TCDD, influenza virus

PMID:
24194396
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24194396
 
Back
Top Bottom